US Patent 9198895 Chroman derivatives, medicaments and use in therapy
Patent 9198895 was granted and assigned to MEI Pharma on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+248 characters)
Article
Patent abstract
Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09198895 Chroman derivatives, medicaments and use in therapy US Patent 9198895 Chroman derivatives, medicaments and use in therapy
Infobox
Patent Number
0919889500
Patent Number
919889500
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
091988950
Date of Patent
December 1, 2015
0Patent Application Number
145899410
Date Filed
January 5, 2015
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
091988950
Date of Patent
December 1, 2015
0Patent Application Number
145899410
Date Filed
January 5, 2015
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09198895 Chroman derivatives, medicaments and use in therapy
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09198895
Date of patent
December 1, 2015
Patent application number
14589941
Date Filed
January 5, 2015
Patent primary examiner
Find more entities like US Patent 9198895 Chroman derivatives, medicaments and use in therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.